Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vyvanse Effects on Brain Hemodynamics and Reading in ADHD
NCT00733356Phase 4Completed
- Sponsor
- Kimberley Lakes
- Start
- Jul 2008
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-blind, single-arm trial of lisdexamfetamine in attention deficit hyperactivity disorder (ADHD), sponsored by Kimberley Lakes. Primary endpoint: Gray Oral Reading Test, Fourth Edition. Started Jul 2008; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00733356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00733356.